Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Blocklisting Six Monthly Return

4 Dec 2012 15:40

RNS Number : 7318S
Ark Therapeutics Group PLC
04 December 2012
 



 

Ark Therapeutics Group plc

4 December 2012

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Ark Therapeutics Group plc

 

2. Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme

 

3. Period of return

From 03/06/2012 - 03/12/2012

 

4. Balance of unallotted securities under scheme from previous return

2,271,252

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6. Less: Number of securities issued/allotted under the scheme during period

Nil

 

7. Equals: Balance under the scheme not yet issued/allotted at end of period

2,271,252

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Ark Therapeutics Group plc

 

2. Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

 

3. Period of return

From 03/06/2012 - 03/12/2012

 

4. Balance of unallotted securities under scheme from previous return

939,433

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6. Less: Number of securities issued/allotted under the scheme during period

Nil

 

7. Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Ark Therapeutics Group plc

 

2. Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

 

3. Period of return

From 03/06/2012 - 03/12/2012

 

4. Balance of unallotted securities under scheme from previous return

683,200

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6. Less: Number of securities issued/allotted under the scheme during period

Nil

 

7. Equals: Balance under the scheme not yet issued/allotted at end of period

683,200

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Ark Therapeutics Group plc

 

2. Name of scheme

Ark Therapeutics Group Approved Share Option Plan

 

3. Period of return

From 03/06/2012 - 03/12/2012

 

4. Balance of unallotted securities under scheme from previous return

1,000,000

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6. Less: Number of securities issued/allotted under the scheme during period

Nil

 

7. Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

0207 388 7722

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSOVRUKAURAA

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.